共 50 条
- [31] Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos) Osteoporosis International, 2005, 16 : 568 - 578
- [32] Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (09): : 1021 - 1025
- [35] Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women BMC Endocrine Disorders, 14
- [39] Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis Osteoporosis International, 2000, 11 : 83 - 91
- [40] Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis Calcified Tissue International, 2020, 107 : 559 - 566